KIMBERLY CLARK CORP
For the period ended Dec 31, 2025. Filed Mar 23, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Dec 31, 2025 · Filed Mar 23, 2026
Contents
Appendix AA-
Appendix A
SUMMARY OF NON-GAAP FINANCIAL MEASURES
The following provides the reconciliation of the non-GAAP financial measures provided in this report to the most closely related GAAP measure. These measures include: Organic Sales Growth, Adjusted Gross Profit, Adjusted Operating Profit, Adjusted Earnings per Share Attributable to Kimberly-Clark, and Adjusted Free Cash Flow.
Organic Sales Growth is defined as the change in Net Sales, as determined in accordance with U.S. GAAP, excluding the impacts of currency translation and divestitures and business exits.
Adjusted Gross and Operating Profit and Adjusted Earnings per Share Attributable to Kimberly-Clark are defined as Gross Profit, Operating Profit, and Diluted Earnings per Share Attributable to Kimberly-Clark (inclusive of discontinued operations), respectively, as determined in accordance with U.S. GAAP, excluding the impacts of certain items that management believes do not reflect our underlying operations, and which are discussed in further detail below.
Adjusted Free Cash Flow is defined as cash provided by operations, as determined in accordance with U.S. GAAP, less capital expenditures and excluding cash charges related to our 2024 Transformation Initiative and our joint venture transaction with Suzano related to our IFP business.
The income tax effect of these non-GAAP items on the Company's Adjusted Earnings per Share is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment. The impact of these non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income Before Income Taxes and Equity Interests and Provision for income taxes.
We use these non-GAAP financial measures to assist in comparing our performance on a consistent basis for purposes of business decision making by removing the impact of certain items that we do not believe reflect our underlying and ongoing operations. We believe that presenting these non-GAAP financial measures is useful to investors because it (i) provides investors with meaningful supplemental information regarding financial performance by excluding certain items, (ii) permits investors to view performance using the same tools that management uses to budget, make operating and strategic decisions, and evaluate historical performance, and (iii) otherwise provides supplemental information that may be useful to investors in evaluating our results. We believe that the presentation of these non-GAAP financial measures, when considered together with the corresponding U.S. GAAP financial measures and the reconciliation to those measures, provides investors with additional understanding of the factors and trends affecting our business than could be obtained absent these disclosures.
These non-GAAP financial measures are not meant to be considered in isolation or as a substitute for the comparable GAAP measures, and they should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP. There are limitations to these non-GAAP financial measures because they are not prepared in accordance with GAAP and may not be comparable to similarly titled measures of other companies due to potential differences in methods of calculation and items being excluded. We compensate for these limitations by using these non-GAAP financial measures as a supplement to the GAAP measures and by providing reconciliations of the non-GAAP and comparable GAAP financial measures.
The non-GAAP financial measures exclude the following items for the relevant time periods (refer to our Annual Report on Form 10-K for the year ended December 31, 2025 for further details on these items):
2024 Transformation Initiative - We initiated this transformation to create a more agile and focused operating structure that will accelerate our proprietary pipeline of innovation in right-to-win spaces and improve our growth trajectory, profitability, and returns on investment.
Kenvue Acquisition - Acquisition-related costs incurred in connection with the pending Kenvue Acquisition, primarily related to external advisory, legal, accounting, and other related costs.
U.S. Tax Reform Related Matters (OBBBA) - In 2025, we recognized a valuation allowance on prior year U.S. foreign tax credits as a result of provisions within the OBBBA that impact our ability to use the credits.
| A-1 | 2026 Proxy Statement |
|---|
Appendix A
IFP Repatriated Earnings – In connection with the IFP Transaction, we recognized a deferred tax liability for certain permanently reinvested earnings from the IFP Business that are expected to be repatriated prior to the close of the transaction.
IFP Separation Costs - In 2025, costs were incurred in connection with the IFP Transaction related to external advisory, legal, accounting, contractor and other incremental costs, and are reported in discontinued operations.
IFP Tax Basis Adjustment - In 2025, in connection with the IFP Transaction, we recognized a deferred tax liability on the difference between our book and tax basis for certain of our investments in subsidiaries reported as discontinued operations.
Sale of PPE Business - In 2024, we recognized a gain related to the sale of our PPE business.
Impairment of Intangible Assets - In 2024, we recognized charges related to the impairment of certain intangible assets related to Softex and Thinx.
Legal Expense - In 2024, we incurred certain costs related to litigation and regulatory matters for a previously exited business.
Softex Tax Reserve Release - In 2024 we released a reserve for an uncertain tax position related to the prior year impairment of certain Softex intangible assets.
The following table provides a reconciliation of Organic Sales Growth from continuing operations:
| Percent change vs. the prior year period | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Net Sales Growth | (2.1) | (2.0) | 1.1 |
| Currency Translation | 0.9 | 4.2 | 3.0 |
| Divestitures and Business Exits | 2.9 | 1.6 | 0.7 |
| Organic Sales Growth(a) | 1.7 | 3.9 | 4.8 |
(a)Table may not foot due to rounding.
The following table provides a reconciliation of Organic Sales Growth (including discontinued operations):
| Percent change vs. the prior year period | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Net Sales Growth | (1.8) | (1.8) | 1.3 |
| Currency Translation | 0.5 | 3.8 | 2.8 |
| Divestitures and Business Exits | 2.4 | 1.2 | 0.6 |
| Organic Sales Growth(a) | 1.1 | 3.2 | 4.7 |
(a)Table may not foot due to rounding.
The following table provides a reconciliation of Adjusted Gross Profit:
| Year Ended December 31 | ||
|---|---|---|
| (in millions) | 2025 | 2024 |
| Gross Profit | $5,923 | $6,289 |
| 2024 Transformation Initiative | 213 | 144 |
| Adjusted Gross Profit | $6,136 | $6,433 |
| 2026 Proxy Statement | A-2 |
|---|
Appendix A
The following table provides a reconciliation of Adjusted Operating Profit:
| Year Ended December 31 | ||
|---|---|---|
| (in millions) | 2025 | 2024 |
| Operating Profit | $2,351 | $2,700 |
| 2024 Transformation Initiative | 348 | 456 |
| Kenvue Acquisition | 32 | — |
| Sale of PPE Business | — | (565) |
| Impairment of Intangible Assets | — | 97 |
| Legal Expense | — | 39 |
| Adjusted Operating Profit | $2,731 | $2,727 |
The following table provides a reconciliation of Adjusted Earnings per Share Attributable to Kimberly-Clark:
| Year Ended December 31 | ||
|---|---|---|
| 2025 | 2024 | |
| Diluted Earnings per Share Attributable to Kimberly-Clark | $6.07 | $7.55 |
| 2024 Transformation Initiative | 0.86 | 1.01 |
| Kenvue Acquisition | 0.07 | — |
| OBBBA | 0.29 | — |
| IFP Separation Costs | 0.18 | — |
| IFP Repatriated Earnings | 0.04 | — |
| IFP Tax Basis Adjustment | 0.02 | — |
| Sale of PPE Business | — | (1.34) |
| Impairment of Intangible Assets | — | 0.17 |
| Legal Expense | — | 0.11 |
| Softex Tax Reserve Release | — | (0.20) |
| Adjusted Earnings per Share Attributable to Kimberly-Clark(a) | $7.53 | $7.30 |
(a)The non-GAAP adjustments included above are presented net of tax. The income tax effect of these non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
The following table provides a reconciliation of Adjusted Free Cash Flow:
| Year Ended December 31 | |||
|---|---|---|---|
| (in millions) | 2025 | 2024 | 2023 |
| Cash Provided by Operations | $2,777 | $3,234 | $3,542 |
| Capital Expenditures | (1,138) | (721) | (766) |
| Cash Restructuring Charges | 229 | 156 | — |
| IFP Separation Costs | 35 | — | — |
| Adjusted Free Cash Flow | $1,903 | $2,669 | $2,776 |
| A-3 | 2026 Proxy Statement |
|---|
Invitation to Stockholders
Notice of 2026 Annual Meeting
Proxy Statement
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.